AI cancer cures slowed by chip shortage, says Arm boss
Arm's chief executive said the global shortage of advanced semiconductor chips is delaying the development of artificial‑intelligence tools for cancer treatment. While AI models have shown promise in identifying therapies, limited access to high‑performance processors slows research and clinical trials. The bottleneck highlights supply chain issues affecting medical AI progress. Arm expects supply to ease later this year.